Scott Paradis

Scott Paradis has extensive experience in pharmaceutical sales, primarily focusing on specialty markets. Currently, Scott is employed at ViiV Healthcare in HIV Injectable Sales since June 2016. Previously, Scott worked at Salix Pharmaceuticals from October 2014 to October 2015, where responsibilities included launching and selling Ruconest for hereditary angioedema. Prior to that, Scott held positions at Merz Pharmaceuticals, where successes included launching a buy and bill injectable biologic, and at H. Lundbeck A/S, where Scott contributed to the launch of multiple CNS products with Orphan Drug Status. Scott began their career at Janssen, progressing from a Primary Care Representative to a Senior Specialty Representative. Scott holds a Bachelor of Science degree in Hospitality Administration/Management from Ohio University.